<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86437</article-id><article-id pub-id-type="doi">10.7554/eLife.86437</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Maresin 1 repletion improves muscle regeneration after volumetric muscle loss</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-224446"><name><surname>Castor-Macias</surname><given-names>Jesus A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190331"><name><surname>Larouche</surname><given-names>Jacqueline A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9380-3547</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305710"><name><surname>Wallace</surname><given-names>Emily C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305711"><name><surname>Spence</surname><given-names>Bonnie D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305712"><name><surname>Eames</surname><given-names>Alec</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-348894"><name><surname>Duran</surname><given-names>Pamela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305713"><name><surname>Yang</surname><given-names>Benjamin A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224444"><name><surname>Fraczek</surname><given-names>Paula M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305714"><name><surname>Davis</surname><given-names>Carol A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110531"><name><surname>Brooks</surname><given-names>Susan V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-147464"><name><surname>Maddipati</surname><given-names>Krishna Rao</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305715"><name><surname>Markworth</surname><given-names>James F</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5348-1464</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-190335"><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3830-0634</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular and Integrative Physiology</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Pathology</institution>, <institution>Wayne State University</institution>, <addr-line><named-content content-type="city">Detroit</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Animal Sciences</institution>, <institution>Purdue University West Lafayette</institution>, <addr-line><named-content content-type="city">West Lafayette</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-160928"><name><surname>Huang</surname><given-names>Christopher L-H</given-names></name><role>Reviewing editor</role><aff><institution>University of Cambridge</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>caguilar@umich.edu</email> (CA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>12</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e86437</elocation-id><history><date date-type="received"><day>26</day><month>01</month><year>2023</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Castor-Macias et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Castor-Macias et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86437-v1.pdf"/><abstract><p>The acute traumatic or surgical loss of skeletal muscle, known as volumetric muscle loss (VML), is a devastating type of injury that results in exacerbated and persistent inflammation followed by fibrosis. The mechanisms that mediate the magnitude and duration of the inflammatory response and ensuing fibrosis after VML remain understudied and as such, the development of regenerative therapies has been limited. To address this need, we profiled how lipid mediators, which are potent regulators of the immune response after injury, varied with VML injuries that heal or result in fibrosis. We observed that non-healing VML injuries displayed increased pro-inflammatory eicosanoids and a lack of pro-resolving lipid mediators. Treatment of VML with a pro-resolving lipid mediator synthesized from docosahexaenoic acid, called Maresin 1, ameliorated fibrosis through reduction of neutrophils and macrophages and enhanced recovery of muscle strength. These results expand our knowledge of the dysregulated immune response that develops after VML and identify a novel immuno-regenerative therapeutic modality in Maresin 1.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>P30 AR069620</award-id><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000090</institution-id><institution>Congressionally Directed Medical Research Programs</institution></institution-wrap></funding-source><award-id>W81XWH2010336</award-id><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000090</institution-id><institution>Congressionally Directed Medical Research Programs</institution></institution-wrap></funding-source><award-id>W81XWH2110491</award-id><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100015579</institution-id><institution>3M Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000965</institution-id><institution>American Federation for Aging Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>2045977</award-id><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000185</institution-id><institution>Defense Advanced Research Projects Agency</institution></institution-wrap></funding-source><award-id>D20AC0002</award-id><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Hevolution Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Aguilar</surname><given-names>Carlos A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were fed normal chow ad libitum and housed on a 12:12 hour light-dark cycle under UM veterinary staff supervision. Allprocedures were approved by the Institutional Animal Care and Use Committee (IACUC) andwere in accordance with the U.S. National Institute of Health (NIH).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE215808</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Aguilar CA</collab><collab>et al</collab></person-group><year iso-8601-date="2023">2023</year><source>Maresin 1 repletion improves muscle regeneration after volumetric muscle loss</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215808">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215808</ext-link><comment>NCBI Gene Expression Omnibus, GSE215808</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-86437-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>